highly significantP < 0.001
Specifically, the prevalence of macrosomia was 7.9% in the <5.1 mmol/L group, 28.2% in the 5.1–7 mmol/L group, and 42.1% in the ≥7 mmol/L group, resulting in a highly significant difference (P < 0.001) ( Table 1 ).
Specifically, the prevalence of macrosomia was 7.9% in the <5.1 mmol/L group, 28.2% in the 5.1–7 mmol/L group, and 42.1% in the ≥7 mmol/L group, resulting in a highly significant difference (P < 0.001) ( Table 1 ).